Clinical features of anti-TIF1-  antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1-  or anti-Mi-2 autoantibodies

Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins

(2011) Manabu Fujimoto et al.   ARTHRITIS AND RHEUMATISM

Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: A systematic review and meta-analysis

(2011) Ernesto Trallero-Araguás et al.   ARTHRITIS AND RHEUMATISM

The Mi-2/NuRD complex: A critical epigenetic regulator of hematopoietic development, differentiation and cancer

(2010) Julita Ramírez et al.   Epigenetics

Anti-MDA5 and anti-TIF1-γ antibodies have clinical significance for patients with dermatomyositis

(2010) Kei Hoshino et al.   RHEUMATOLOGY

Dermatomyositis and polymyositis

(2009) Andrew L. Mammen   Annals of the New York Academy of Sciences

Optimization of immunoprecipitation–western blot analysis in detecting GW182-associated components of GW/P bodies

(2009) Joanna J Moser et al.   Nature Protocols

Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression

(2009) H. Gunawardena et al.   RHEUMATOLOGY